# ARRDC3 tyrosine phosphorylation functions as a switch to control c-Src versus WWP2 interactions and distinct scaffolding functions

**Authors:** Mika Caplan, Carolyne Bardeleben, Kanika Dhawan, Rhea Plawat, Irina Kufareva, JoAnn Trejo

PMC · DOI: 10.1016/j.jbc.2025.110270 · The Journal of Biological Chemistry · 2025-05-21

## TL;DR

This study shows how a specific phosphorylation site in the protein ARRDC3 controls its interactions with different proteins, influencing its function in cellular signaling.

## Contribution

The paper identifies a novel phosphorylation site in ARRDC3 that acts as a regulatory switch for distinct protein interactions.

## Key findings

- ARRDC3 Y394 phosphorylation promotes interaction with c-Src and regulates its activity.
- Non-phosphorylated ARRDC3 binds to WWP2 and supports lysosomal trafficking of a GPCR.
- Phosphorylation at Y394 disrupts WWP2 interaction and alters ARRDC3 scaffolding functions.

## Abstract

Mammalian α-arrestins are members of the same arrestin family as the ubiquitously expressed and extensively studied β-arrestins. Arrestins share common structural elements, including the conserved N- and C-arrestin-fold domains, polar core, finger loop, and C-terminal tail, all of which mediate protein–protein interactions. In β-arrestins, these domains enable the control of G protein-coupled receptor (GPCR) signaling and scaffolding interactions with various signaling proteins including c-Src. By contrast, the repertoire of α-arrestin scaffolding partners and regulatory mechanisms that control their interactions are not well-understood. α-arrestins differ considerably from β-arrestins in the C-terminal region; β-arrestins contain clathrin adaptor β-adaptin-binding sites, whereas α-arrestins harbor PPxY motifs, demonstrated to interact with WW domains of E3 ubiquitin ligases such as WWP2. Here we report the identification of a novel phosphorylation site, tyrosine (Y) 394, embedded in the C-terminal PPxY motif of α-arrestin ARRDC3. The Y394 site functions as a phospho-regulatory switch to enable distinct ARRDC3 binding partners and scaffolding functions. We found that ARRDC3 Y394 phosphorylation promotes interaction with c-Src via its SH2 domain, whereas the non-phosphorylated form binds to WWP2. Our results further show that ARRDC3 Y394 phosphorylation and c-Src SH2 domain-dependent interaction enables regulation of c-Src activity, whereas ARRDC3 Y394 phosphorylation disrupts WWP2 interaction and perturbs ARRDC3-dependent lysosomal trafficking of the GPCR, protease-activated receptor-1. Together, these findings indicate that ARRDC3 Y394 functions as a phospho-regulatory switch to enable selective binding to different partners that impact distinct scaffolding functions.

## Linked entities

- **Genes:** ARRDC3 (arrestin domain containing 3) [NCBI Gene 57561], SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714], WWP2 (WW domain containing E3 ubiquitin protein ligase 2) [NCBI Gene 11060]
- **Proteins:** ARRDC3 (arrestin domain containing 3), SRC (SRC proto-oncogene, non-receptor tyrosine kinase), WWP2 (WW domain containing E3 ubiquitin protein ligase 2)

## Full-text entities

- **Genes:** ARRDC3 (arrestin domain containing 3) [NCBI Gene 57561] {aka TLIMP}, CXCR6 (C-X-C motif chemokine receptor 6) [NCBI Gene 10663] {aka BONZO, CD186, CDw186, STRL33, TYMSTR}, WWP2 (WW domain containing E3 ubiquitin protein ligase 2) [NCBI Gene 11060] {aka AIP2, WWp2-like}, F2R (coagulation factor II thrombin receptor) [NCBI Gene 2149] {aka CF2R, HTR, PAR-1, PAR1, TR}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12213294/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12213294/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12213294/full.md

---
Source: https://tomesphere.com/paper/PMC12213294